Skip to main content

Institutional intelligence for Concord Biotech Ltd.

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Tracked super investors holding ≥1%

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters44.08%
  • FII7.52%
  • Mutual Funds4.40%
  • DII (ex-MF)4.96%
  • Retail & others39.04%
  • Super Investors 24.09%(subset)
  • 1% Club 10.93%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

44.08%3 named
HolderStakeSharesValue (₹ Cr)
28.84%3,01,69,524₹3.88k Cr
9.55%99,87,636₹1.28k Cr
4.54%47,52,000₹611.2 Cr

Retail & others

Holders below 1% disclosure threshold and public non-institutions

39.04%

SEBI requires naming only shareholders with ≥1% stake. The remaining 39.04% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

Super Investors

Curated tracked investor profiles

24.09%3 named

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

10.93%7 named
HolderStakeSharesValue (₹ Cr)
2.48%25,90,472₹333.2 Cr
2.00%20,92,325₹269.1 Cr
1.75%18,28,753₹235.2 Cr
1.34%13,99,464₹180.0 Cr
1.20%12,56,432₹161.6 Cr
1.11%11,63,833₹149.7 Cr
1.05%11,00,000₹141.5 Cr

FII / FPI

Foreign portfolio investors

7.52%1 named
HolderStakeSharesValue (₹ Cr)
2.95%30,91,239₹397.6 Cr

DII (other)

Insurance, banks, AIF, other domestic institutions

4.96%No names

No named holders ≥1% in this bucket.

Mutual Funds

Domestic mutual funds & UTI

4.40%No names

No named holders ≥1% in this bucket.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.